Screener / SEC EDGAR /CIK 0001674416 /10-K filed Feb 12, 2026, compared with Feb 11, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

CRISPR Therapeutics AG CRSP

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 10 Form 144 notices for $15.9M

10-Q, 10-K and Form 144
Plans running now 5 Raju Prasad, James R. Kasinger, Naimish Patel, Simeon J. George, Katherine A. High
Plans adopted 14 reported since May 8, 2023 Form 144 notices 10 $15.9M the sellers expected to sell

What CRSP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jun 11, 2024 to May 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Raju Prasad
Chief Financial Officer
Adopted 10b5-1 plan Jun 9, 2026 10-Q Aug 3, 2026
James R. Kasinger
General Counsel and Secretary
Adopted 10b5-1 plan May 6, 2026 10-Q Aug 3, 2026
Naimish Patel
M.D. (Chief Medical Officer)
Adopted 10b5-1 plan Dec 16, 2025 10-K Feb 12, 2026
Simeon J. George
M.D. (Member of the Board of Directors)
Adopted 10b5-1 plan Dec 12, 2025 10-K Feb 12, 2026
Katherine A. High
M.D. (Member of the Board of Directors)
Adopted 10b5-1 plan Nov 14, 2025 10-K Feb 12, 2026
Samarth Kulkarni
Chief Executive Officer
Ended 10b5-1 plan Aug 27, 2025 10-Q Nov 10, 2025
Raju Prasad,
Chief Financial Officer
Adopted 10b5-1 plan Aug 18, 2025 10-Q Nov 10, 2025
James R. Kasinger
General Counsel
Adopted 10b5-1 plan Aug 6, 2025 10-Q Nov 10, 2025
Samarth Kulkarni
Chief Executive Officer
Adopted 10b5-1 plan Jun 10, 2025 10-Q Aug 4, 2025
Samarth Kulkarni
Chief Executive Officer
Adopted 10b5-1 plan Jun 13, 2024 10-Q Aug 5, 2024
Raju Prasad
Chief Financial Officer
Adopted 10b5-1 plan Jun 11, 2024 10-Q Aug 5, 2024
Jim Kasinger
General Counsel and Secretary
Adopted 10b5-1 plan Mar 4, 2024 10-Q May 8, 2024
Dr. Katherine High
Adopted 10b5-1 plan Dec 6, 2023 10-K Feb 21, 2024
Dr. Samarth Kulkarni
Chief Executive Officer and Chairman of our Board of Directors
Adopted 10b5-1 plan Sep 15, 2023 10-Q Nov 6, 2023
Dr. Phuong Khanh Morrow
Chief Medical Officer
Adopted 10b5-1 plan Sep 7, 2023 10-Q Nov 6, 2023
Show the other 7 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 6, 2026 RAJU PRASAD
Officer
79,393 $4.0M
Oct 14, 2026 SIMEON GEORGE
Director
14,514 $720K
Oct 6, 2026 JAMES KASINGER
Officer
1,990 $119K
Sep 22, 2026 JAMES KASINGER
Officer
10,400 $626K
Sep 17, 2026 ALI BEHBAHANI
Director
13,679 $781K
Jan 22, 2026 Samarth Kulkarni
Officer
60,000 $3.6M
Jan 22, 2026 RAJU PRASAD
Officer
34,972 $2.1M
Jan 20, 2026 Samarth Kulkarni
Officer
30,000 $1.6M
Jan 6, 2026 RAJU PRASAD
Officer
29,700 $1.8M
Dec 22, 2025 RAJU PRASAD
Officer
10,000 $560K
Show the other 2 notices

From the Form 144 XML filed with the SEC, since Dec 22, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CRSP/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.